Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin‐3, and NT‐ProBNP Before Cardiac Surgery

Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin‐3, and NT‐ProBNP Before Cardiac Surgery

Background Current preoperative models use clinical risk factors alone in estimating risk of in‐hospital mortality following cardiac surgery. However, novel biomarkers now exist to potentially improve preoperative prediction models. An assessment of Galectin‐3, N‐terminal pro b‐type natriuretic pept...

Full description

Bibliographic Details
Main Authors: Sai Polineni, Devin M. Parker, Shama S. Alam, Heather Thiessen‐Philbrook, Eric McArthur, Anthony W. DiScipio, David J. Malenka, Chirag R. Parikh, Amit X. Garg, Jeremiah R. Brown
Format: Article
Language:English
Published: Wiley 2018-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiac biomarkers
cardiac surgery
mortality
outcomes research
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.008371

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.008371

Similar Items